These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38677767)

  • 1. Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
    Wagner D; Karitnig R; Wienerroither V; Hau HM; Lederer A; Sucher R; Kornprat P
    Anticancer Res; 2024 May; 44(5):2177-2183. PubMed ID: 38677767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
    Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
    Kocher NJ; Jafri S; Balabhadra S; Lehman E; Gardner J; Vijay K; Sarwani N; Raman JD
    Urol Oncol; 2018 Apr; 36(4):156.e17-156.e22. PubMed ID: 29276063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative sarcopenia predicts survival after hepatectomy for colorectal metastases: a prospective observational study.
    Pessia B; Romano L; Carlei F; Lazzari S; Vicentini V; Giuliani A; Schietroma M
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5619-5624. PubMed ID: 34604954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection.
    Dello SA; Lodewick TM; van Dam RM; Reisinger KW; van den Broek MA; von Meyenfeldt MF; Bemelmans MH; Olde Damink SW; Dejong CH
    HPB (Oxford); 2013 Mar; 15(3):165-9. PubMed ID: 23020663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases.
    Runkel M; Diallo TD; Lang SA; Bamberg F; Benndorf M; Fichtner-Feigl S
    World J Surg; 2021 Jul; 45(7):2218-2226. PubMed ID: 33842995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 14. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
    Vashi PG; Gorsuch K; Wan L; Hill D; Block C; Gupta D
    PLoS One; 2019; 14(6):e0218761. PubMed ID: 31220163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases.
    Halazun KJ; Aldoori A; Malik HZ; Al-Mukhtar A; Prasad KR; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2008 Jan; 34(1):55-60. PubMed ID: 17448623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body composition and outcome in patients undergoing resection of colorectal liver metastases.
    van Vledder MG; Levolger S; Ayez N; Verhoef C; Tran TC; Ijzermans JN
    Br J Surg; 2012 Apr; 99(4):550-7. PubMed ID: 22246799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of association between CT-assessed skeletal muscle mass and long-term oncological outcomes after curative therapy for colorectal liver metastasis.
    Meyer YM; Galjart B; Waalboer RB; Olthof PB; van Vugt JLA; Grünhagen DJ; Verhoef C
    HPB (Oxford); 2022 Oct; 24(10):1711-1719. PubMed ID: 35550727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
    Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
    Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.